Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Feb 7, 2025 - 15:00

Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Zepbound and Mounjaro have now underperformed expectations for two straight quarters.

Related Posts

Canes re-sign Robinson to 4-year, $6.8M deal

Canes re-sign Robinson to 4-year, $6.8M deal

Jun 20, 2025

Ex-Blackhawk Toews signing with hometown Jets

Ex-Blackhawk Toews signing with hometown Jets

Jun 20, 2025

Stanley Cup ratings drop, lower than 4 Nations

Stanley Cup ratings drop, lower than 4 Nations

Jun 20, 2025

Stars deal Marchment to Kraken for 2 draft picks

Stars deal Marchment to Kraken for 2 draft picks

Jun 20, 2025

Diamonds in the rough: Late-round gems of the 2025 draft

Diamonds in the rough: Late-round gems of the 2025 draft

Jun 23, 2025

Avalanche re-up Stienburg, Polin to 1-year deals

Avalanche re-up Stienburg, Polin to 1-year deals

Jun 20, 2025